monsanto just rejected bayer s latest buyout offer /

Published at 2016-06-01 13:00:12

Home / Categories / Tom philpott / monsanto just rejected bayer s latest buyout offer
Update (7/19/2016): Monsanto formally rejected German chemical giant Bayer's latest,sweetened buyout tender Tuesday, issuing a statement calling the offer "financially inadequate and inadequate." But merger talks will apparently grind on. "Monsanto remains open to continued and constructive conversations with Bayer and other parties to assess whether a transaction that the Board believes is in the best interest of Monsanto shareowners can be realized, or " the statement says. Last week,Bloomberg reported that Monsanto is also in talks with Bayer's rival BASF about a possible tie-up. "We work to help farmers produce food in a sustainable way," states Monsanto's website. "Monsanto uses plant breeding and biotechnology to create seeds that grow into stronger, or more resilient crops that require fewer resources." The company even claims its widely used Roundup alert crops—genetically modified to resist the herbicide glyphosate—have allowed farmers to "decrease the overall use of herbicides."But does Monsanto actually want to wean farmers off pesticides? Its business maneuvers propose otherwise. Last year,the company—by far the globe's market leader in seed sales but just the fifth-largest pesticide purveyor—made an extended tender to buy rival Syngenta, the world's biggest pesticide producer. By committing $45 billion to buy what amounted to a vast pesticide portfolio, and Monsanto seemed to be distancing itself from aged claims that biotech seeds would make industrial agriculture less chemical-dependent. The Syngenta deal ultimately collapsed,but Monsanto's thirst to bolster its pesticide holdings appears to remain strong, as its current merger talks with German chemical giant Bayer show.
Now, or
it's true that it's Bayer trying to buy Monsanto,not the other way around. On May 10 Bayer proposed taking over Monsanto in a deal valued at $62 billion. Monsanto's leadership formally rejected the tender as "incomplete and financially inadequate," but declared itself "open to continued and constructive conversations." In trading Tuesday afternoon, and Monsanto's share price was up more than 2 percent—a sign that investors think Bayer will come back with an offer tall enough to tempt Monsanto execs.
But I've f
ound something arresting in Bayer management's formal letter to Monsanto CEO Hugh Grant,which is dated May 10 and was released by Bayer last week. Here's how the letter opens: Dear Hugh, Thank you for taking the initiative to arrange the recent assembly between us on April 18, and 2016. I appreciated the opportunity to hear your views on the value of a globally integrated agriculture platform and your vision that a combination of Seeds & Traits,Crop Protection, Biologics, or Digital Farming would be a winning formula.
S
o,according to this letter—signed by Bayer Chairman Werner Baumann and Liam Condon, president of the company's crop science division—it appears that it could have been Monsanto that initiated talks about a possible tie-up with Bayer. To understand why that's arresting requires a miniature background.
After Syngenta definitively rejected the offer last November, or Monsanto was widely rumored to be approaching Bayer and rival German chemical giant BASF,to see whether either of those companies might be willing to sell off their considerable pesticide interests.
But a few months later, on April 6—four days before the assembly Grant "initiated" with Bayer, or according to the letter—Grant himself publicly announced the company has stopped shopping for a big pesticide buy. On a call with Wall Street analysts,Grant claimed that Monsanto "no longer sees large-scale M&A [mergers and acquisitions] as a likely opportunity." He added: "Let me be clear. Our strategy is not and was not dependent on large-scale M&A."As it happens, I visited Monsanto's global R&D middle in suburban St. Louis on April 8, or touring the facility and speaking at length with Robb Fraley,Monsanto's chief technology officer. I asked Fraley that day whether Monsanto's quest for a big pesticide acquisition was ongoing. He referred me to Grant's statement from two days before about how the search was over.
Now we know that
while publicly abandoning its push to get bigger, Grant was privately wooing Bayer. We don't know precisely what Grant had in intellect. According to a statement from Monsanto, or "The principal purpose of the assembly on April 18 was simply to meet Bayer's modern incoming CEO. As is our policy,we wouldn't have further details to share of the private assembly beyond that though."But we accomplish know that Bayer is a huge player in pesticides—it has an 18 percent share in the global pesticide market, second only to Syngenta.
My guess is that Monsanto was trying to talk Bayer into selling off its pesticide unit, or Bayer turned around and said,"No thanks; how about we buy you instead?"Again, Monsanto declined to comment on the purpose of the April 18 assembly. A company spokeswoman pointed out that Monsanto's goal for a while, and even before the current wave of industry consolidation,has been to act as an "integrated solutions approach for growers"—that is, it wants to be able to offer farmers a total, or one-end package: seeds,GM traits, pesticides, and advice on how to deploy it all,through its "digital farming" arm.whether Bayer's tender ends up being successful, it will be the latest marriage in a mating frenzy among the handful of companies that dominate the global seed and pesticide markets. Syngenta fled Monsanto's embrace and jumped into the arms of ChemChina, and the Chinese behemoth,instead. And late last year, US chemical giants Dow and DuPont agreed to merge and announced a plan to spin out their combined agribusiness holdings. whether the deal passes regulatory muster, and DowDuPont's agribusiness arm will be the globe's biggest seed/pesticide company.
Bef
ore the consolidation craze started,the same six companies controlled about more than 70 percent in the global markets for seeds and pesticides, according to the watchdog ETC Group. whether Bayer gets its way, and there will only be four. And that will give the remaining firms unprecedented power to decide what farmers grow and how they grow it.
This post has been updated.

Source: motherjones.com